WallStSmart

Sabra Healthcare REIT Inc (SBRA)vsVentas Inc (VTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 650% more annual revenue ($5.82B vs $775.76M). SBRA leads profitability with a 20.1% profit margin vs 4.3%. VTR appears more attractively valued with a PEG of 1.74. SBRA earns a higher WallStSmart Score of 57/100 (C).

SBRA

Buy

57

out of 100

Grade: C

Growth: 5.3Profit: 6.5Value: 4.7Quality: 5.3
Piotroski: 5/9Altman Z: 0.46

VTR

Buy

55

out of 100

Grade: C

Growth: 7.3Profit: 5.0Value: 4.7Quality: 3.8
Piotroski: 4/9Altman Z: 0.39
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

SBRASignificantly Overvalued (-350.6%)

Margin of Safety

-350.6%

Fair Value

$4.35

Current Price

$19.84

$15.49 premium

UndervaluedFair: $4.35Overvalued
VTRSignificantly Overvalued (-591.0%)

Margin of Safety

-591.0%

Fair Value

$12.40

Current Price

$82.70

$70.30 premium

UndervaluedFair: $12.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SBRA4 strengths · Avg: 8.3/10
Profit MarginProfitability
20.1%9/10

Keeps 20 of every $100 in revenue as profit

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

Operating MarginProfitability
23.7%8/10

Strong operational efficiency at 23.7%

Revenue GrowthGrowth
15.8%8/10

15.8% revenue growth

VTR2 strengths · Avg: 8.0/10
Operating MarginProfitability
20.3%8/10

Strong operational efficiency at 20.3%

Revenue GrowthGrowth
21.4%8/10

Revenue surging 21.4% year-over-year

Areas to Watch

SBRA4 concerns · Avg: 2.8/10
P/E RatioValuation
31.0x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
5.6%3/10

ROE of 5.6% — below average capital efficiency

PEG RatioValuation
3.152/10

Expensive relative to growth rate

EPS GrowthGrowth
-44.7%2/10

Earnings declined 44.7%

VTR4 concerns · Avg: 3.0/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Return on EquityProfitability
2.2%3/10

ROE of 2.2% — below average capital efficiency

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

P/E RatioValuation
153.2x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : SBRA

The strongest argument for SBRA centers on Profit Margin, Price/Book, Operating Margin. Profitability is solid with margins at 20.1% and operating margin at 23.7%. Revenue growth of 15.8% demonstrates continued momentum.

Bull Case : VTR

The strongest argument for VTR centers on Operating Margin, Revenue Growth. Revenue growth of 21.4% demonstrates continued momentum.

Bear Case : SBRA

The primary concerns for SBRA are P/E Ratio, Return on Equity, PEG Ratio.

Bear Case : VTR

The primary concerns for VTR are PEG Ratio, Return on Equity, Profit Margin. A P/E of 153.2x leaves little room for execution misses. Thin 4.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

VTR carries more volatility with a beta of 0.76 — expect wider price swings.

VTR is growing revenue faster at 21.4% — sustainability is the question.

VTR generates stronger free cash flow (368M), providing more financial flexibility.

Monitor REIT - HEALTHCARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SBRA scores higher overall (57/100 vs 55/100), backed by strong 20.1% margins and 15.8% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Sabra Healthcare REIT Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 skilled nursing / transitional care facilities, (ii) 64 senior housing communities (?

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Want to dig deeper into these stocks?